Siamed'Xpress Overview
- Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$88K
- Investors
-
1
Siamed'Xpress General Information
Description
Operator of bio-proteins platform intended for research, therapeutics, and diagnostics with serum-like glycosylation. The company's product is highly sialylated, serum-like, glycoproteins designed to make it possible to humanize the clones producing therapeutic proteins in order to prolong their activity, enabling the reduction of the doses injected and side effects.
Contact Information
Website
www.siamedxpress.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
- Hôtel Technologique Morandat
- 1480 avenue d'Arménie
- 13120 Gardanne
- France
+33 04 00 00 00 00
Siamed'Xpress Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 13-Dec-2016 | $88K | 0000 | 00000 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | 21-May-2012 | Completed | Generating Revenue |
Siamed'Xpress Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 000.000000 | 000.00 | 000.00 | 00 | 000.00 | 000 |
Siamed'Xpress Patents
Siamed'Xpress Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3019601-B1 | Methods for producing sialylated therapeutic proteins | Active | 11-Jul-2013 | 0000000000 | |
| EP-3019601-A1 | Methods for producing sialylated therapeutic proteins | Active | 11-Jul-2013 | 0000000000 | |
| EP-2824176-A1 | Methods for producing sialylated therapeutic proteins | Inactive | 11-Jul-2013 | 0000000000 | 00 |
| US-20160153020-A1 | Methods for producing sialylated therapeutic proteins | Active | 11-Jul-2013 | 0000000000 | |
| US-10421985-B2 | Methods for producing sialylated therapeutic proteins | Active | 11-Jul-2013 | C12P21/005 | 00 |
Siamed'Xpress Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Catherine Ronin-Vaisse Ph.D | Founder, Chief Executive Officer and President |
Siamed'Xpress Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |